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Summary  In  a  multi-center,  prospective,  observational  study  over  two  inﬂuenza
seasons,  we  sought  to  quantify  and  correlate  the  amount  of  virus  recovered  from  the
nares  of  infected  subjects  with  that  recovered  from  their  immediate  environment  in
community  and  hospital  settings.  We  recorded  the  symptoms  of  adults  and  children
with  A(H1N1)pdm09  infection,  took  nasal  swabs,  and  sampled  touched  surfaces  and
room  air.  Forty-two  infected  subjects  were  followed  up.  The  mean  duration  of  virus
shedding  was  6.2  days  by  PCR  (Polymerase  Chain  Reaction)  and  4.2  days  by  culture.
Surface  swabs  were  collected  from  39  settings;  16  (41%)  subject  locations  were  con-
taminated  with  virus.  Overall,  33  of  the  671  (4.9%)  surface  swabs  were  PCR  positive
for  inﬂuenza,  of  which  two  (0.3%)  yielded  viable  virus.  On  illness  Day  3,  subjects
yielding  positive  surface  samples  had  signiﬁcantly  higher  nasal  viral  loads  (geometric
mean  ratio  25.7;  95%  CI  1.75,  376.0,  p  =  0.021)  and  a  positive  correlation  (r  =  0.47,
p  =  0.006)  was  observed  between  subject  nasal  viral  loads  and  viral  loads  recovered
from  the  surfaces  around  them.  Room  air  was  sampled  in  the  vicinity  of  12  subjects,
and  PCR  positive  samples  were  obtained  for  ﬁve  (42%)  samples.  Inﬂuenza  virus  shed
by  infected  subjects  did  not  detectably  contaminate  the  vast  majority  of  surfaces
sampled.  We  question  the  relative  importance  of  the  indirect  contact  transmission  of
inﬂuenza  via  surfaces,  though  our  data  support  the  existence  of  super-spreaders  via
this  route.  The  air  sampling  results  add  to  the  accumulating  evidence  that  supports
 nuclei  (aerosol)  transmission  of  inﬂuenza.
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We  conducted  a multi-center,  prospective,
observational  cohort  study  over  two  inﬂuenza
seasons, comprising  the  second  and  third  waves  ofthe  potential  for  droplet
©  2015  King  Saud  Bin  Ab
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ittle  is  deﬁnitively  known  about  the  modes  of
nﬂuenza  transmission  and  their  relative  impor-
ance, and  important  health  policy  and  infection
ontrol issues  remain  unresolved.  The  World  Health
rganization,  the  Centers  for  Disease  Control  and
revention  (CDC),  the  European  Centre  for  Dis-
ase Prevention  and  Control  and  the  U.S.  Institute
f Medicine  have  each  prioritized  improving  the
nderstanding  of  inﬂuenza  transmission  as  a crit-
cal component  for  pandemic  preparedness  and
esponse  [1—3].
Inﬂuenza  transmission  begins  with  the  produc-
ion of  virus  containing  particles  by  actions  such  as
oughing and  sneezing,  which  generate  an  ‘expi-
atory  spray’  containing  particles  varying  in  size
rom <1  to  1000  m.  The  majority  are  small  and
ave a  geometric  mean  diameter  of  13.5  m  during
oughing  [4].  Large  droplets  (typical  size  >20  m)
eposit on  mucous  surfaces  of  the  upper  respira-
ory tract  (URT),  such  as  the  mouth  and  nose;  they
an be  inhaled,  but  are  too  large  to  reach  the  lungs.
roplet  nuclei  (frequently  called  aerosols;  typically
5 m)  are  inhaled  and  can  reach  the  lower  respi-
atory tract  (LRT)  [5]. Contact  transmission  involves
he transfer  of  particles  to  the  mucous  membranes
ither directly,  e.g.,  via  kissing,  or  indirectly  via
ands or  fomites.
t
2
2
ULaboratory  studies  have  conﬁrmed  the  ability
f human  inﬂuenza  virus  to  survive  in  these  envi-
onments  [6—8],  but  few  studies  have  attempted
o investigate  its  presence,  quantity  and  viabil-
ty around  infected  patients.  In  previous  research,
iral shedding  has  mostly  been  determined  by  the
easurement  of  the  virus  that  is  recoverable  from
he nasopharynx,  i.e.,  via  a deliberately  performed
nvasive technique.  Such  ‘viral  shedding’  studies  in
act measure  the  virus  shed  from  infected  cells  into
he nasopharynx  but  do  not  actually  measure  the
mount of  virus  deposited  into  the  environment
on surfaces  or  in  the  air);  therefore,  they  imply
ut do  not  deﬁne  environmental  contamination  and
he actual  hazard  posed  to  others.  In  this  study,  we
escribe viral  shedding  and  its  relationship  to  symp-
om duration,  illness  severity  and  the  amount  of
irus recovered  from  the  immediate  environment.
ethodshe 2009/10  pandemic  in  England  [September
009—January  2010  (Year  1)  &  December
010—January  2011  (Year  2)].  An  accredited
K Research  Ethics  Committee  approved  the  study.
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Participants
Adults  and  children  (<16  years)  in  hospitals  and  in
the community  were  recruited  from  three  sites  in
the UK.  Written  informed  consent  was  obtained  at
enrolment  for  all  participants.
Screening and eligibility criteria
We  approached  patients  who  had  an  inﬂuenza-like
illness (ILI)  deﬁned  as:  fever  (or  recent  history  of
fever) and  any  one  of  cough,  sore  throat,  runny
nose, fatigue  or  headache  OR  any  two  of  cough,  sore
throat, runny  nose,  fatigue  or  headache.  A  rapid
antigen test  (Quidel  QuickVue®)  was  used  to  assist
with the  early  diagnosis  of  cases  (but  positivity
was not  an  inclusion  criterion).  We  excluded  cases
where  illness  had  been  present  for  >48  h  (commu-
nity cases)  or  >96  h  (hospital  cases).
Study procedures
Where  possible,  subjects  were  followed  up  on  a
daily basis  for  a  maximum  of  12  days.  A  symptom
diary was  completed  at  each  visit.
A nasal  swab,  performed  by  a  nurse  or  physician,
was taken  by  rotating  a  swab  round  one  ante-
rior nare  three  times.  Surface  swabs  were  taken
in hospital  rooms  and  in  the  subjects’  own  homes
from pre-deﬁned  surfaces  (Table  A,  supplemen-
tary data).  The  swabs  were  moistened  with  viral
transport  medium  (VTM  —  Remel  M4RT®)  and  then
rubbed across  an  area  of  approximately  100  cm2
in  three  different  directions  while  applying  even
pressure.
Nasal  and  surface  swabs  were  placed  into  VTM
and  kept  on  ice  for  no  longer  than  3  h before  being
frozen at  −70 ◦C.
Air particles  were  collected  using  a  National
Institute for  Occupational  Safety  and  Health  two-
stage cyclone  bioaerosol  sampler  that  separates
particles into  3  size  fractions  [<1  m  (stage  1),
1—4 m  (stage  2)  and  >4  m  (stage  3)]  and  has  been
validated for  use  with  inﬂuenza  [9,10]. Sampling
was usually  performed  on  only  one  day.  The  ﬂow
rate through  each  sampler  was  set  to  3.5  L/min  with
a ﬂow  calibrator  (Model  4143,  TSI).  Samplers  were
mounted  on  tripods  at  a  height  of  150  cm,  placed
approximately 2  m  from  the  subject  and  run  for
1—3 h.  After  sampling,  VTM  was  added  to  both  stage
1 and  2  tubes  and  the  ﬁlter  paper  from  stage  3
was immersed  in  a  15-ml  tube  containing  VTM.  The
samples were  stored  at  −70 ◦C.
Further  details  are  provided  in  Supplementary
Table A.
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irological assessments
olymerase  Chain  Reaction  (PCR):  a novel  inﬂuenza
(H1N1)  pentaplex  assay  was  devised  to  detect
he virus  genome  in  the  samples.  The  assay  was
esigned  to  detect  A(H1N1)pdm09,  seasonal  H1  and
3 inﬂuenza  A,  inﬂuenza  B  and  an  internal  con-
rol bacteriophage  MS2.  It  is  highly  sensitive  and
as a very  wide  dynamic  range  (10  logs)  and  can
eliably detect  as  few  as  3.85  genome  equivalents
er PCR  reaction.  The  performance  of  the  assay
as been  assessed  on  multiple  occasions  by  Health
rotection  Agency/Public  Health  England  exter-
al quality  assessment  panels.  Viral  load  data  for
(H1N1)pdm09  were  generated  using  a PCR  assay
nd a plasmid  containing  the  hemagglutinin  (HA)
ene target  to  create  a  standard  curve,  such  that
he concentration  of  the  genome  present  in  each
ample  could  be  estimated.
Culture:  an  immunoﬂuorescence  (IF)  assay  was
sed to  detect  the  inﬂuenza  A/B  nucleoprotein  to
emonstrate  the  presence  of  live  replicating  virus
11].
Further  methodological  detail  is  provided  in  the
upplementary  Data  section.
The  following  sample  processing  rules  were
nstituted to  limit  the  analysis  of  likely  negative
amples:
. Nasal  swabs  from  day  4  onwards  were  not  tested
if days  1—3  were  all  PCR  negative.
. Culture  was  only  performed  on  PCR  positive  sam-
ples.
. Environmental  swabs  were  not  processed  if  nasal
swabs  taken  on  the  three  previous  days  from  a
case were  PCR  negative.
utcome measures
irus  shedding  (nasal  swab)
 positive  nasal  swab  was  deﬁned  as  a sam-
le in  which  a cycle  threshold  (Ct)  value  of  <35
2342 copies/ml)  for  ≥1  triplicate  of  a sample  was
btained  (a  Ct  value  of  35  is  a  log  up  from  the  identi-
ed limit  of  detection  of  the  assay).  Unexplainable
esults and  any  single  triplicates  separated  by  >48  h
rom other  positive  samples  were  disregarded.  Viral
oads represent  the  geometric  mean  (GM)  value  of
he triplicate  assay.  A  value  of  half  of  the  lower  limit
f detection  was  imputed  for  undetectable  values.
he duration  of  virus  shedding  was  deﬁned  as  the
ime between  symptom  onset  and  the  last  day  that
 positive  specimen  was  obtained.  Because  subjects
ere seldom  recruited  on  the  day  that  symptoms
egan, an  assumption  was  made  that  they  were
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Fig.  1  Participant  ﬂow  diagram.  Note:  ‘Others’  consisted  of  inﬂuenza-like  illness  with  no  conﬁrmed  viral  etiology
or  conﬁrmed  infections  with  rhinovirus  or  respiratory  syncytial  virus  (RSV).  Two  inﬂuenza  A(H1N1)pdm09  cases  were
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sxcluded  on  the  basis  of  being  recruited  >5  days  after  sy
hedding  virus  from  the  ﬁrst  day  of  symptoms  to
he last  positive  specimen  day.
ubject symptoms
aily symptom  scores  were  categorized  into  the
i) URT  score;  (ii)  the  LRT  score;  (iii)  the  systemic
core; and  (iv)  the  total  symptom  score  (sum  of  URT,
RT and  systemic  scores  plus  a  score  for  diarrhea
nd/or vomiting).  Individual  symptoms  were  given
 severity  score  of  0—3.  A  similar  index  has  previ-
usly been  used  to  assess  respiratory  tract  illnesses
f viral  etiology  [12].
nvironmental  deposition  (surfaces  and  air
amples):
 positive  surface  swab  or  air  sample  was  deﬁned  as
 sample  in  which  a  Ct  value  of  <35  for  ≥1  triplicate
f a  sample  was  obtained.  Post  hoc,  a  Ct  value  of
40 (122  copies/ml)  for  ≥1  triplicate  of  a  sample,
f it  was  obtained  from  a  subject  with  a  positive
ose swab  taken  on  the  same  day  (to  help  conﬁrm
lausibility), was  deﬁned  as  positive.  Reducing  the
hreshold of  detection  to  limit  false  negative  results
as considered  to  be  reasonable  based  on  our  own
ata that  showed  false  positives  to  be  unlikely;  only
 swab  (Ct  =  39.5)  was  excluded  because  of  a nega-
ive nose  swab  on  the  same  day.tatistical methods
 descriptive  analysis  of  the  data  is  presented.  Stu-
ent’s t-tests  were  used  to  compare  mean  values;
S
T
c
(m  onset.
earson’s  correlation  tests  were  used  to  determine
ssociations between  continuous  variables;  and
dds Ratios  (ORs)  and  95%  conﬁdence  intervals
CIs) represent  associations  between  variables  with
inary categorical  outcome  measures.  Chi-squared
ests were  used  to  test  the  signiﬁcance  of  ORs.  Dif-
erences in  viral  loads  were  measured  using  GMs
nd compared  using  GM  ratios  and  paired  t-tests.  p
alues ≤0.05  were  considered  to  be  signiﬁcant.  All
tatistical analyses  were  conducted  in  Stata  version
1 (Statacorp,  Inc.).
esults
emography, treatment and outcomes
ne-hundred-two  subjects  with  ILI  were  studied,  49
48%) of  whom  had  a  conﬁrmed  inﬂuenza  infection;
4 (90%)  had  A(H1N1)pdm09  (age  range  0—58);  and
 (10%)  had  inﬂuenza  B  (age  range  5—66)  (Fig.  1).
wo patients  with  A(H1N1)pdm09  were  excluded
rom analysis  because  they  were  recruited  outside
f the  speciﬁed  timeframe.  Therefore,  data  from
2 patients  with  conﬁrmed  A(H1N1)pdm09  cases  are
resented in  this  paper.  The  demography  of  these
ubjects  is  shown  in  Table  1.
ymptomshe  most  frequently  reported  symptoms  were
ough (93%),  sore  throat  (88%)  and  rhinorrhea
86%). During  follow  up,  the  symptom  scores  were
282  B.  Killingley  et  al.
Table  1  Demographic  characteristics  of  the  participants,  treatments,  and  outcomes.
Setting
AC  CC  AH  CH  Total  n  (%)
Enrolled  13  11  14  4  42
Female  sex 8  3  9  4  24  (57%)
Median  age  (years)  29  4  28  2.5  22
Range  21—58  2—12  19—57  0—15  0—58
Ethnic  group
White  10  8  8  4  30  (71%)
Black  1  0  1  0  2  (5%)
Asian  2  1  5  0  8  (19%)
Other  0  2  0  0  2  (5%)
Mean  time  from  symptom  start  to
enrolment  (days)
2.2  1.5  2.4  2.8  2.1  (range  0—4)
Mean  duration  of  follow  up  (days)  5.6  8.3  5.9  7.5  6.6  (range  1—12)
Rapid  antigen  test  positive  3/13  (23%)  7/9  (78%)  5/14  (36%)  1/4  (25%)  16  (40%)
Antiviral  treatment  any/within  48  h  0/0  4/3  13/8  3/1  20/12  (48/29%)
High  dependency  care/died  during
follow  up
0/0 0/0  1/0  1/0  2/0
Note: AC = adult community, CC = child community, AH = adult hospital, CH = child hospital.
highest  on  Day  3  of  symptomatic  illness  and
declined thereafter  (Fig.  2).
Virus shedding
PCR
The  mean  duration  of  shedding  was  6.2  days  from
symptom onset  (range  2—15  days,  interquartile
range 5—7).  There  was  no  signiﬁcant  differ-
ence between  adults  and  children  [mean  dif-
ference = 0.29  (95%  CI:  −1.33,  1.90),  p  =  0.720]
(Fig.  3A).
Viral loads  varied  widely,  ranging  from  2033  to
24,521,397  copies/ml,  and  declined  over  time.  No
signiﬁcant  differences  were  observed  in  the  GM
viral loads  between  adults  vs.  children  and  com-
munity  vs.  hospital  cases  on  illness  Days  3,  4  and  5
(Table  B,  supplementary  data).
Fig.  2  The  mean  symptom  scores  of  A(H1N1)pdm09
cases  over  time.  Footnote:  data  only  shown  where  ≥3
observations  were  available
Culture
Twenty-four  of  39  cases  (62%)  were  culture  positive
for A(H1N1)pdm09  (insufﬁcient  sample  was  avail-
able for  culture  in  three  cases).  The  mean  duration
of shedding  by  culture  was  4.6  days  (range  3—10
days, interquartile  range  4—5).  Ten  of  39  (26%)
Fig.  3  The  percentage  of  subjects  who  shed  virus  against
time.  (A)  Shedding  by  PCR.  (B)  Shedding  by  culture.
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invironmental  deposition  of  inﬂuenza  virus  
ubjects  shed  live  virus  for  at  least  ﬁve  days  from
he onset  of  illness  (Fig.  3B).
nvironmental deposition
urfaces
ultiple  surface  swabs  were  collected  in  39
eparate locations  (houses  and  hospital  rooms)
nhabited by  subjects,  some  of  whom  lived
ogether; 16  premises  (41%)  were  contaminated
ith virus.  A  mean  of  16  swabs  (range  6—42)  were
aken  from  each  location,  ≥2  positive  samples
ere obtained  from  8 of  the  16  premises.  In  total,
71 collected  swabs  were  tested  and  inﬂuenza
(H1N1)pdm09  was  detected  by  PCR  in  33  (4.9%).
eventeen  surface  samples  (selected  on  the  basis
f PCR  results  with  low  Ct  values)  were  examined
or viable  virus,  and  two  surfaces  (a  games  console
nd a  kettle  handle)  were  positive,  representing
1.7% of  the  samples  cultured  and  0.3%  of  the  total
amples  taken)  (Table  C,  supplementary  data).
ir
amples were  collected  from  the  immediate  envi-
onment  of  12  subjects  (Season  1  =  5,  Season  2 =  7).
ubjects were  targeted  on  the  basis  of  a  positive
apid test,  early  in  the  course  of  illness,  conve-
ience and  special  interest  (HDU  cases);  six  were
n the  hospital,  nine  were  adults  and  eight  were
apid antigen  test  positive.  These  samples  were
ositive  by  PCR  for  ﬁve  subjects  (42%)  (Table  2).
irus was  detected  in  all  of  the  particle  size  frac-
ions collected;  7/26  (27%)  of  the  collections  for
articles  <1  m  were  positive;  9/27  (33%)  of 1—4-
m particles  were  positive  and  7/27  (26%)  of  >4-m
articles  were  positive.  No  signiﬁcant  associations
ere found  with  respect  to  the  sampling  distance  or
ime and  the  ﬁnding  of  positive  samples.  Viral  loads
anged  between  238  and  24,231  copies/ml.  No  air
amples were  positively  cultured.
he relationship between symptoms, virus
hedding and virus deposition
ymptoms  and  viral  load
oor correlations  were  observed  between  the  total
ymptom  scores  and  log  transformed  nasal  viral
oads on  illness  Day  3  (day  of  maximum  symp-
oms) (r  =  −0.063;  p  = 0.751)  and  Day  4  (r  =  −0.07;
 =  0.69).iral  load  and  surface  deposition  of  virus
n illness  Day  3,  a  signiﬁcantly  higher  GM  viral  load
as observed  in  those  who  had  surface  positive
wabs compared  to  those  who  did  not  (GM  ratio
i
t
[
t283
5.7;  95%  CI  1.75,  376.0,  p  =  0.021)  (Table  3). A  pos-
tive correlation  (r  =  0.47,  p  =  0.006)  was  observed
etween the  log  transformed  subject  nasal  viral
oads and  viral  loads  recovered  from  surfaces  on
llness  Day  3  (r  =  0.38,  p  =  0.03).
ymptoms  and  surface  deposition  of  virus
here were  statistically  signiﬁcant  ﬁndings  for  URT
ymptoms  and  similar  but  non-signiﬁcant  trends  for
RT symptoms,  which  suggest  that  patients  with
igher symptom  scores  reﬂected  in  the  likelihood  of
here being  inﬂuenza  positive  surface  swabs  taken
rom the  environment  (Table  3).
ymptoms,  viral  load  and  virus  deposition  in  air
here were  no  differences  in  the  GM  viral  loads
n illness  Day  4  or  in  the  LRT  and  URT  scores  on
llness  Days  3 and  4 between  those  with  positive
nd negative  air  samples  (Table  D,  supplemen-
ary data).
iscussion
his  is  the  ﬁrst  study  to  examine  the  relationship
etween inﬂuenza  virus  shedding  from  the  nose
ith virus  deposition  in  the  air  and  on  surfaces  from
he patient’s  immediate  environment,  in  both  inpa-
ient and  home  settings.  As  such,  it  offers  important
nformation for  infection  prevention  and  control
ractices.
Our ﬁndings  on  the  duration  of  virus  shedding
re broadly  in  agreement  with  published  ﬁndings
oncerning seasonal  inﬂuenza  and  A(H1N1)pdm09
13—16],  although  we  did  not  identify  a signiﬁcant
orrelation between  symptoms  and  viral  load  where
thers have  done  so.  Virus  was  detected  on  sur-
aces in  the  near  environment  of  38%  of  subjects.
verall, however,  virus  was  infrequently  isolated
y PCR  from  surface  swabs  (4.9%),  and  on  only
wo occasions  was  live  (infectious)  virus  recovered.
hese data  suggest  that  although  environmental
ontamination  occurs,  it is  not  usually  extensive  or
eavy.
To our  knowledge,  there  are  no  data  concern-
ng the  infectious  dose  for  indirect  contact  routes;
owever, we  believe  that  the  following  data  helps
ustify  our  conclusion.  The  ratio  of  the  tissue  cul-
ure infectious  dose  50  (TCID50)  to  the  number  of
irions (and  therefore  to  the  number  of  genome
opies) for  inﬂuenza  A  has  been  estimated  by  var-
ous authors  [17—19].  Assuming  that  the  1  TCID50
s equal  to  400  genome  copies/ml,  then  an  infec-
ious  aerosol  dose  (calculated  to  be  0.6—3  TCID50)
20]  would  be  240—1200  copies/ml  and  an  infec-
ious intranasal  dose  (100—1000  TCID50)  [21—23]
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Table  2  Positive  air  sample  results  by  location,  age,  particle  size,  and  virus  copies/ml.
Adult Adul t Chil d  Chil d Adu lt 
Subject 
setting 
(+ infected 
others) 
Hospital bed  in 
side  room 
Hospital bed  in  side 
room 
Playing in  living  room 
(6-year-old infected child 
also present) 
Cot on  neonatal 
unit 
(2 infected 
neonates also 
present on  ward) 
Bedroom
Illness  Day of 
sampling 
45334
Nasal  Viral 
Load 
(copies/ml) 
173,000 8,250,000  24,520,000  18,480,000  4000 
Any surface 
swabs  
positive 
No 
Yes 
(Day 4) 
oNoN
Yes 
(Day 3) 
Room 
Temperature 
(0C) 
0.710.420.813.326.12
Room 
Humidit y 
(relative  %) 
4404060505
Duration of 
sampling 
(hours) 
1 3 1 2 1 3 3 3 
Approximate 
distance  from 
subject (m) 
1-2 ≥2 1-2 ≥2 1-2  ≥2  ≥2 1-2  ≥2 1-2  ≥2 1-2  ≥2  ≥2 
Particle size 
detected in 
(µm)  
<1 
1068 
<1 
238
1-4 1-4 
   <1 
13199
1-4 
<1 
5156
1-4 1-4 
<1 
2149 
1-4 
<1 
2577 
1-4 
<1 
1287 
1-4 1-4 
PCR 
copies/ml 
258
>4 
511
603 5179 
>4 
8210 
7107
>4 
4028
24231
>4 
5603 
5166 
>4 
4889 
3527 
>4 
3639 
3889 
>4 
2245 
5388 
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Table  3  Viral  loads  and  symptom  scores  compared  between  those  with  positive  and  those  with  negative  surface
swabs.
Illness
day
GM nasal  VL  surface  positive
(95%  CI)
GM  nasal  VL  surface  negative
(95%  CI)
GM  ratio  p  value
Day  3  464,225.5  (79,759.9,  2,701,927.0)  18,072.4  (1573.2,  207,613.6)  25.7  (1.75,  376.0)  0.021
Day  4  77,514.8  (7301.8,  822,885.5)  118,788.1  (19,080.1,  739,547.4)  0.7  (0.0,  10.5)  0.753
Illness
day
Mean  URT  score  surface
positive
Mean  URT  score  surface
negative
Mean  difference  p  value
Day  3  8.5  3.9  −4.6  0.002
Day  4  6.6  3.6  −3.0  0.009
Illness
day
Mean  LRT  score  surface
positive
Mean  LRT  score  surface
negative
Mean  difference  p  value
Day  3  4.2  3.2  −1.0  0.140
Day  4  3.8  2.7  −1.1  0.051
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ould  be  40,000—400,000  copies/ml.  The  differ-
nce in  the  infectious  dose  between  aerosol  and
irect nasal  inoculation  is  at  least  2 logs.  It  is likely
hat the  infectious  dose  for  aerosol  transmission
s also  signiﬁcantly  less  than  that  needed  for  indi-
ect contact  transmission.  The  copy  number  range
or environmental  swabs  was  100—43,000,  with  a
edian of  1200  copies/ml.  We  argue  that  while
8% of  subjects  contaminate  their  surroundings,  the
mount of  virus  recovered  from  the  vast  major-
ty of  environmental  swabs  does  not  represent  an
nfectious  dose.
Our  data  show  similarities  to  ﬁndings  from  a ran-
omized  trial  that  investigated  hand  hygiene  and
urface contamination  in  Thailand  [24,25].  How-
ver, our  results  contrast  with  those  of  a  study  that
etected  inﬂuenza  virus  on  over  50%  of  all  swabs
aken from  a  number  of  surfaces  in  the  home  and  in
hild care  centers  [26].  Differences  between  stud-
es may  be  inﬂuenced  by  the  strain  of  inﬂuenza
irus; the  subjects  involved;  swabbing  and  detec-
ion methods,  including  the  timing  of  swabbing  and
he surfaces  selected;  environmental  conditions;
nd the  proportions  of  subjects  taking  antiviral
rugs. Indeed  we  have  demonstrated  some  of  these
oints in  the  current  study.  Both  swabbing  and  lab-
ratory  processing  were  more  selective  in  Year  2,  as
e attempted  to  target  surface  samples  that  had  a
reater chance  of  positivity;  the  swab  positive  rates
1.4 vs.  10.7%)  reﬂect  this.  For  example,  4  out  of
 chosen  surfaces  in  Year  1 (bedside  table,  dining
able, patient  table  and  windowsill)  were  not  items
hat could  be  picked  up  or  grasped  by  the  hand,
nd in  many  instances,  they  were  made  of  wood,
 material  that  does  not  support  virus  survival  [27]
see  supplementary  data).
e
a
f
s tract, LRT = lower respiratory tract.
Two  randomized  clinical  trials  (RCTs)  supporting
he indirect  contact  route  of  transmission  have
hown  signiﬁcant  effects  of  hand  hygiene  on  the
ncidence  of  laboratory  conﬁrmed  inﬂuenza  and
bsenteeism  due  to  ILI  in  school  children  [28,29].
ther RCTs  report  negative  ﬁndings  [30—32], and
 systematic  review  and  meta-analysis  found  no
igniﬁcant  effect  of  hand  hygiene  on  the  reduc-
ion of  laboratory  conﬁrmed  inﬂuenza  infections
33]. Notwithstanding  any  positive  trial  results
which may  reﬂect  a reduction  in  transmission  that
nvolves hand  to  hand  or  hand  to  face  touching
ut not  fomites),  the  indirect  contact  route  trans-
ission  pathway  seems  to  be  implausible.  How
ikely is  it  that  an  infectious  dose  of  virus  can
ersist while  passing  along  a transmission  chain?
esearchers  studying  rhinovirus  transmission  con-
luded that  an  infective  dose  of  virus  is  unlikely  to
each the  end  of  a  transmission  chain  [34]. Based  on
ur data,  we  question  how  frequently  an  infectious
ose of  inﬂuenza  virus  persists  while  passing  from
nfected  secretions,  to  touched  surfaces  (our  data),
o hands,  and  ﬁnally,  to  mucous  membranes  to  ini-
iate infection  in  a second  person.  We  argue  that
his may  be  rarer  than  is  often  reﬂected  in  infection
ontrol guidance  for  inﬂuenza  where  hand  hygiene
s often  centrally  emphasized.
If the  amount  of  virus  released  is  key  to  transmis-
ion, then  individuals  who  release  the  most  virus,  so
alled ‘super-producers’  or  ‘super-spreaders’,  are
ikely to  be  better  transmitters  than  others  [35].
he amount  of  virus  released  by  individuals  is  gov-
rned by  a  number  of  factors,  of  which  the  viral  load
nd symptoms  are  most  important.  The  ﬁndings
rom our  study  support  the  concept  that  super-
preaders of  inﬂuenza  infection  via  the  indirect
o
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contact  route  might  exist.  On  illness  Day  3,  nasal
viral loads  were  signiﬁcantly  higher  in  those  with
positive  surface  swabs  compared  to  those  with  neg-
ative surface  swabs,  and  a  signiﬁcant  correlation
between nasal  and  surface  viral  loads  was  found.
Furthermore,  the  symptom  scores  were  generally
higher (signiﬁcantly  so  for  the  URT  scores)  in  those
with positive  surface  swabs.  These  ﬁndings  suggest
that individuals  who  release  the  most  virus  into  the
environment  are  likely  to  be  responsible  for  the
most surface  contamination  and  therefore  for  the
majority of  transmissions  that  occur  via  the  indirect
contact  route.  In  practical  terms,  we  suggest  that
the intuitive  feeling  that  patients  with  high  viral
loads and  strong  symptoms  have  the  characteris-
tics that  makes  them  the  most  likely  individuals  to
contaminate  surfaces  is  indeed  likely  to  be  correct.
Inﬂuenza  virus  has  been  detected  (by  PCR)  in
air samples  taken  from  medical  facilities  [9,36,37]
and  from  the  directly  exhaled  breath  and  coughs  of
infected  patients  [38—40]. Our  study  demonstrates
that samples  of  air  collected  from  around  infected
subjects contain  inﬂuenza  virus.  All  of  the  particle
sizes collected  contained  virus  that  was  detectable
by PCR,  notably  including  the  <1  m  and  1—4  m
fraction sizes,  which  are  respirable  (they  can  reach
the distal  airways  of  the  respiratory  tract)  [5],  and
health attendants  require  respirators,  not  surgical
masks,  to  avoid  exposure.  Different  sampling  times
did not  always  run  concurrently,  which  may  explain
why longer  sampling  times  did  not  always  result  in
more virus  being  collected,  as  speciﬁc  ‘shedding
events’ would  not  have  been  captured  equally.
Attempts  can  be  made  to  understand  whether
the PCR  copy  number  found  in  the  air  samples
could represent  an  infectious  dose.  Again  assuming
that 1  TCID50  is  equal  to  400  genome  copies/ml,
then an  infectious  aerosol  dose  (calculated  to  be
0.6—3 TCID50)  [30]  would  be  240—1200  copies/ml.
Our samplers,  operating  at  3.5  L/min,  commonly
collected these  amounts.  By  way  of  comparison,
an adult  human  typically  inhales  6 L/min.  If  the
virus collected  is  infectious,  then  the  majority  of
positive samples  collected  during  this  study  could
contain  infectious  doses  of  inﬂuenza.  Although  we
were unable  to  culture  virus  from  any  air  samples,
the detection  of  live  virus  in  air  samples  is  known
to be  methodologically  challenging;  the  difﬁculties
include virus  fragility,  especially  its  susceptibility
to desiccation,  and  the  fact  that  the  concentration
of virus  being  sampled  in  the  air  is low.  Thus,  fail-
ure to  identify  live  virus  in  air  samples  does  not
necessarily exclude  its  presence.
There are  a  number  of  limitations  to  this  study.
First, the  difﬁculty  in  recruiting  subjects  early  in
the course  of  their  illness  meant  that  the  data
N
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n  the  initial  days  of  illness  were  not  collected.
he ﬁrst  few  days  of  illness  are  usually  times  of
eak symptoms  and  viral  shedding  (and  by infer-
nce, environmental  deposition).  Due  to  logistic
onstraints,  most  analyses  could  only  be  attempted
n illness  days  3  and  4.  Second,  the  comparison
f symptom  data  between  adults  and  children  is
mperfect.  The  data  collection  method  was  the
ame, and  while  this  some  allows  for  a  compar-
son, it  is  clear  that  its  interpretation  must  be
uarded, as  responses  to  the  symptom  diary  card
n children  and  adults  may  be  different.  A  speciﬁc
roblem arises  when  parents  estimate  symptoms  on
he behalf  of  younger  children.  Third,  the  major-
ty of  subjects  from  around  whom  air  samples  were
btained  (including  all  of  those  with  positive  sam-
les) were  selected  on  the  basis  of  a  positive  rapid
ntigen  test.  This  may  have  biased  the  air  sampled
roup  somewhat  and  led  to  a high  proportion  of  pos-
tive air  samples,  as  a  positive  rapid  antigen  test  has
een associated  with  higher  nasal  viral  loads  [41].
inally, no  measurements  or  estimates  of  room  air
ow patterns  or  ventilation  were  made  when  col-
ecting samples.  Such  parameters  are  likely  to  have
n inﬂuence  on  the  ability  to  detect  virus  in  the  air.
Detecting  virus,  particularly  live  virus  in  the
nvironment,  is  challenging;  accessing  the  subject
arly in  the  course  of  illness,  executing  optimal
ampling while  preserving  virus  viability,  and  per-
orming  sensitive  detection  tests  in  the  laboratory
re all  key  factors  and  present  logistical  challenges.
hile based  on  limited  data,  these  ﬁndings  are
f sufﬁcient  importance  to  justify  further  efforts
o reproduce  them,  including  further  attempts  to
etect live  virus,  as  they  have  potentially  important
mplications  for  infection  control  strategies.
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